Alpha 2.0
Login Register
» Articles » PMID: 33011336

Carbapenemase-producing Enterobacterales Outbreak: Another Dark Side of COVID-19

Overview
Journal Am J Infect Control
Specialty Infectious Diseases
Date 2020 Oct 4
PMID 33011336
Citations 32
Authors
Eric Farfour
Marion Lecuru
Laurent Dortet
Morgan Le Guen
Charles Cerf
Francoise Karnycheff
Remy A Bonnin
Marc Vasse
Philippe Lesprit
Affiliations
Soon will be listed here.
Abstract

In the hospital department dedicated to COVID-19-patient, infection prevention and control measures were upgraded. Therefore, the cross-transmission of other micro-organisms was thought unlikely to occur. However, we report an outbreak of NDM-5-producing Escherichia. coli in a 12-beds ICU dedicated to COVID-19 patients. This outbreak involved 6 patients of which 5 were asymptomatic carriers and 1 was infected. Several findings might have contributed to cross-transmission including the multiple-bedroom configuration of the department, uncomplete compliance for standard and contact precautions, overwork due to the burden of the disease, lack of training of staff for the care of ICU-patients, and misuse of gloves. Furthermore, as infection prevention and control measures were thought to be applied, contact patients were not screened for eXDR carriage. Applying rigorously standard and contact precautions and performing screening in contact patients when indicated must be the rules in COVID-19 wards.

Citing Articles

Trends in Healthcare-Acquired Infections Due to Multidrug-Resistant Organisms at a German University Medical Center Before and During the COVID-19 Pandemic.

Kolbe-Busch S, Djouela Djoulako P, Stingu C Microorganisms. 2025; 13(2).

PMID: 40005641 PMC: 11858357. DOI: 10.3390/microorganisms13020274.

National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study.

Echegorry M, Marchetti P, Sanchez C, Olivieri L, Faccone D, Martino F Antibiotics (Basel). 2025; 13(12.

PMID: 39766529 PMC: 11672406. DOI: 10.3390/antibiotics13121139.

Profile of bacterial resistance in emergency wards, non-intensive care unit areas, and intensive care units in Mexican hospitals with the antimicrobial stewardship program.

Garza-Gonzalez E, Nunez-Martinez M, Zuniga-Mejia P, Marquez-Monzon D, Morfin-Otero M, Rodriguez-Noriega E IJID Reg. 2024; 13:100474.

PMID: 39624253 PMC: 11609382. DOI: 10.1016/j.ijregi.2024.100474.

Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis.

Li W, Yang X, Liu C, Liu X, Shi L, Zeng Y Front Public Health. 2024; 12:1419344.

PMID: 39086796 PMC: 11288819. DOI: 10.3389/fpubh.2024.1419344.

Impact of the coronavirus disease 2019 pandemic on the incidence of other infectious diseases in the hematology hospital in Korea.

Oh S, Sung Y, Jang M, Kim Y, Park H, Nho D Korean J Intern Med. 2024; 39(3):513-523.

PMID: 38649159 PMC: 11076895. DOI: 10.3904/kjim.2023.508.

References
1.
Legeay C, Thepot-Seegers V, Pailhories H, Hilliquin D, Zahar J . Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience. J Hosp Infect. 2018; 99(4):390-395. DOI: 10.1016/j.jhin.2018.02.003. View
2.
Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A . Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. Cochrane Database Syst Rev. 2020; 4:CD013582. PMC: 7173761. DOI: 10.1002/14651858.CD013582. View
3.
Mathers A, Vegesana K, German-Mesner I, Ainsworth J, Pannone A, Crook D . Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species. J Hosp Infect. 2020; 104(4):456-468. PMC: 7193892. DOI: 10.1016/j.jhin.2020.01.005. View
4.
Farfour E, Ballester M, Lecuru M, Verrat A, Imhaus E, Mellot F . COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis. J Hosp Infect. 2020; 105(2):375-376. PMC: 7194691. DOI: 10.1016/j.jhin.2020.04.021. View
5.
Girlich D, Bonnin R, Bogaerts P, De Laveleye M, Huang D, Dortet L . Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate. Antimicrob Agents Chemother. 2016; 61(2). PMC: 5278702. DOI: 10.1128/AAC.01697-16. View